Gautam Das – Mibiome Therapeutics Llp
View Detailed Executive Profile →Professional Overview
- In 2020, Gautam Das co-founded miBiome Therapeutics LLP and took on the role of Chief Executive Officer, focusing on innovative microbiome-based therapeutic solutions.
- Gautam Das has also been serving as the Chief Scientific Adviser at Microbiome Research Pvt Ltd since September 2020, contributing expertise in scientific research related to microbiomes.
- In April 2025, Gautam Das is set to take on the position of Chief Growth Officer at Jatayu Healthcare Technologies, indicating a commitment to expanding healthcare technology initiatives.
- Prior to miBiome, Gautam Das held significant positions at Reliance Industries Limited, including Assistant Vice-President & Head of Biomaterials Research, showcasing leadership in R&D and innovative materials.
- Gautam Das served as General Manager for multiple teams at Reliance Industries, leading research initiatives in biotechnology and genetic modification, demonstrating a robust background in scientific leadership and innovation.
- Held a position as Freelance Consultant - Science from October 2019 to January 2020, providing scientific consultancy services, which reflects versatility and adaptability in various scientific sectors.
- Gautam Das has contributed as a Visiting Scientist at Matrix Genetics and Aurora Biofuels, which emphasizes a diverse involvement in various research initiatives and collaborations globally.
- Earlier career milestones include postdoctoral research roles at esteemed institutions such as the University of Massachusetts Medical School and New York University School of Medicine, establishing a solid foundation in academic research.
- Prior positions as a CSIR-Senior Research Fellow and Graduate Student at the Indian Institute of Science contributed to extensive research training and expertise in the biological sciences.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Independent Consultant | Freelance Consultant - Science | Oct 2019 – Jan 2020 |
| Reliance Industries Limited | General Manager - R&D; Team Lead - Genetic Modification and Genomics | Mar 2016 – Mar 2017 |
| Aurora Biofuels | Visiting Associate | Jun 2015 – Aug 2015 |
| Matrix Genetics | Visiting Scientist | Jan 2015 – Feb 2015 |
| Indian Institute of Science (IISc) | Graduate Student | Jan 2001 – Jan 2007 |
| Indian Immunologicals Limited | Summer Student | Jan 2000 – Jan 2000 |
| Algenol | Visiting Associate | Feb 2016 – Feb 2016 |
| University of Massachusetts Medical School | Postdoctoral Research Associate | Feb 2008 – Mar 2013 |
| Matrix Genetics | Visiting Scientist | Dec 2013 – Jan 2014 |
| New York University School of Medicine | Postdoctoral Research Associate | Aug 2007 – Jan 2008 |
| Indian Institute of Science (IISc) | CSIR-Senior Research Fellow | Aug 2001 – Jul 2007 |
| Reliance Industries Limited | Asst. Vice-President & Head, Biomaterials Research | Apr 2018 – Sep 2019 |
| Reliance Industries Limited | General Manager - R&D; Group Lead - Biotechnology/Synthetic Biology | Apr 2017 – Mar 2018 |
| Reliance Industries Limited | Senior Manager - R &D; Team Lead/Senior Research Scientist - Genetic Modification | Apr 2013 – Feb 2016 |
| Microbiome Research Pvt Ltd | Chief Scientific Adviser | Sep 2020 – Present |
| miBiome Therapeutics LLP | Co-Founder & Chief Executive Officer | Jan 2020 – Present |
| Jatayu Healthcare Technologies | Chief Growth Officer | Apr 2025 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Mibiome Therapeutics Llp corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Gautam Das's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Mibiome Therapeutics Llp's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)